Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors

Por Chakrabarty, Anindita, Sánchez, Violeta, Kuba, María G., Rinehart, Cammie, Arteaga, Carlos L.
Publicado em 2012

Lethal Neonatal Meningoencephalitis Caused by Multi-Drug Resistant, Highly Virulent Escherichia coli

Por Iqbal, Junaid, Dufendach, Kevin R., Wellons, John C., Kuba, Maria G., Nickols, Hilary H., Gómez-Duarte, Oscar G., Wynn, James L.
Publicado no Infect Dis (Lond) (2016)

Discordant cellular response to pre-surgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification

Por Balko, Justin M., Mayer, Ingrid A., Sanders, Melinda E., Miller, Todd W., Kuba, Maria G., Meszoely, Ingrid M., Wagle, Nikhil, Garraway, Levi A., Arteaga, Carlos L.
Publicado em 2012

Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression or signaling

Por Young, Christian D., Pfefferle, Adam D., Owens, Philip, Kuba, María G., Rexer, Brent N., Balko, Justin M., Sánchez, Violeta, Cheng, Hailing, Perou, Charles M., Zhao, Jean J., Cook, Rebecca S., Arteaga, Carlos L.
Publicado em 2013

Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer

Por Dennison, Jennifer B., Molina, Jennifer R., Mitra, Shreya, González-Angulo, Ana M., Balko, Justin M., Kuba, María G., Sanders, Melinda E., Pinto, Joseph A., Gómez, Henry L., Arteaga, Carlos L., Brown, Robert E., Mills, Gordon B.
Publicado em 2013

A kinome-wide screen identifies the Insulin/IGF-1 receptor pathway as a mechanism of escape from hormone dependence in breast cancer

Por Fox, Emily M., Miller, Todd W., Balko, Justin M., Kuba, Maria G., Sánchez, Violeta, Smith, R. Adam, Liu, Shuying, González-Angulo, Ana María, Mills, Gordon B., Ye, Fei, Shyr, Yu, Manning, H. Charles, Buck, Elizabeth, Arteaga, Carlos L.
Publicado em 2011

ErbB3 downregulation enhances luminal breast tumor response to antiestrogens

Por Morrison, Meghan M., Hutchinson, Katherine, Williams, Michelle M., Stanford, Jamie C., Balko, Justin M., Young, Christian, Kuba, Maria G., Sánchez, Violeta, Williams, Andrew J., Hicks, Donna J., Arteaga, Carlos L., Prat, Aleix, Perou, Charles M., Earp, H. Shelton, Massarweh, Suleiman, Cook, Rebecca S.
Publicado em 2013

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

Por Miller, Todd W., Balko, Justin M., Fox, Emily M., Ghazoui, Zara, Dunbier, Anita, Anderson, Helen, Dowsett, Mitch, Jiang, Aixiang, Smith, R. Adam, Maira, Sauveur-Michel, Manning, H. Charles, González-Angulo, Ana M., Mills, Gordon B., Higham, Catherine, Chanthaphaychith, Siprachanh, Kuba, Maria G., Miller, William R., Shyr, Yu, Arteaga, Carlos L.
Publicado em 2011

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Por Balko, Justin M, Cook, Rebecca S, Vaught, David B, Kuba, María G, Miller, Todd W, Bhola, Neil E, Sanders, Melinda E, Granja-Ingram, Nara M, Smith, J Joshua, Meszoely, Ingrid M, Salter, Janine, Dowsett, Mitch, Stemke-Hale, Katherine, González-Angulo, Ana M, Mills, Gordon B, Pinto, Joseph A, Gómez, Henry L, Arteaga, Carlos L
Publicado em 2012

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

Por Balko, Justin M., Giltnane, Jennifer M., Wang, Kai, Schwarz, Luis J., Young, Christian D., Cook, Rebecca S., Owens, Phillip, Sanders, Melinda E., Kuba, Maria G., Sánchez, Violeta, Kurupi, Richard, Moore, Preston D., Pinto, Joseph A., Doimi, Franco D., Gómez, Henry, Horiuchi, Dai, Goga, Andrei, Lehmann, Brian D., Bauer, Joshua A., Pietenpol, Jennifer A., Ross, Jeffrey S., Palmer, Gary A., Yelensky, Roman, Cronin, Maureen, Miller, Vincent A., Stephens, Phillip J., Arteaga, Carlos L.
Publicado em 2013